about
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. To...
Read More
25.87
0.36
(1.41%)
95.9M
XNYS Volume
XNYS 12 Nov, 2025 4:30 PM (EST)
Acquisition
Pfizer enters obesity drug market with $10 bn Metsera acquisition as Novo Nordisk exits bidding war
See details
High Financial Strength
Affordable Valuation
Technically Moderately Bullish
Strong Performer
These stock companies have strong financials and are affordably priced. They also score high in quality and technical aspects which makes them a favourite amongst investors.
View Similar
Embed DVM
Pfizer Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..